MIRANDA HERNLY: Open Payments
NPI 1831815216 · AUSTIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 97 payments from 18 companies in 2025. Trend: 2023 $1,158 · 2024 $1,397 · 2025 $1,369
Food & beverage: $1,369
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 29 | $292 |
| ABBVIE INC. | 22 | $262 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Indivior Inc. | 2 | $47 |
| ViiV Healthcare Company | 2 | $40 |
Products named: CAPLYTA, LYBALVI, VRAYLAR, TRINTELLIX, REXULTI, MOUNJARO, VIVITROL, ARISTADA.
Industry payments across IN — which companies pay providers there.
